IP Library Granted Patent US 7,557,573
Granted Patent B2
US 7,557,573 · App. 10/537,235 · Granted Jul 7, 2009

NMR-based methods for detecting ligands, where the ligand or target are hyperpolarized and the NMR-spectrum is compared with a reference spectrum of the ligand or target

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,557,573
App. No.
10/537,235
Granted
Jul 7, 2009
Kind
B2
Abstract

The invention relates to NMR-based methods comprising hyperpolarised ligands or targets for use in NMR-based assays.

Claims (13)

1. An NMR-based method comprising the steps of:

a) hyperpolarising at least one of a ligand and a target, wherein said at least one of a ligand and a target is isotopically enriched with at least one of 12 C and 15 N NMR active nuclei,

b) forming a mixture by contacting either the at least one hyperpolarised ligand with one of a target and both a target and at least one further ligand or the hyperpolarised target with at least one ligand,

c) generating a NMR spectrum of the mixture, and

d) comparing said NMR spectrum with a reference spectrum of the at least one hyperpolarised ligand or the hyperpolarised target.

2. The method according to claim 1 , wherein the at least one ligand is selected from the group consisting of proteins, glycoproteins, lipoproteins, polypeptides, glyco-polypeptides, lipopolypeptides, peptides, carbohydrates, nucleic acids or a part, a fragment or a complex thereof and small organic molecules.

3. The method according to claim 1 , wherein the at least one ligand is a small organic molecule of less than 2000 Da.

4. The method according to claim 1 , wherein more than one hyperpolarised ligand is used.

5. The method according to claim 1 , wherein the target is selected from the group consisting of proteins, glycoproteins, lipoproteins, nucleic acids, polypeptides, glycopolypeptides, lipopolypeptides, peptides or a part, a fragment or a complex thereof.

6. The method according to claim 1 , wherein the enrichment is a hu 13 C-enrichment.

7. The method according to claim 1 , wherein the NMR spectrum generated is a one-dimensional NMR spectrum.

8. The method according to claim 1 , wherein the NMR spectrum generated is generated using low flip angles.

9. The method according to claim 1 , wherein the comparison with the reference spectrum shows a chemical shift difference, a relaxation time difference or a NOE effect difference.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 3, 2009
From: ARDENKJAER-LARSEN, JAN-HENRIK; BAUMANN, HERBERT; COTTON, GRAHAM JOHN; GOLMAN, KLAES; HOWARD, MARK; LERCHE, MATHILDE H.; SERVIN, ROLF; THANING, MIKKEL; WOLBER, JAN
To: AMERSHAM HEALTH AS
Reel/Frame 022771/0954 →
CHANGE OF NAME Recorded Jun 3, 2009
From: AMRESHAM HEALTH AS
To: GE HEALTHCARE AS
Reel/Frame 022774/0391 →
LICENSE AGREEMENT Recorded Sep 21, 2007
From: GE HEALTHCARE AS (FORMERLY AMERSHAM HEALTH AS)
To: OXFORD INSTRUMENTS MOLECULAR BIOTOOLS LIMITED
Reel/Frame 019884/0268 →
CHANGE OF NAME Recorded Aug 2, 2006
From: AMERSHAM HEALTH AS; NYCOMED IMAGING AS
To: GE HEALTHCARE AS
Reel/Frame 018039/0537 →